Cargando…

De novo podocytopathy following moderna COVID-19 vaccine: A case report and racial disproportionality in adverse effect reports

In this study, we report a case of de novo minimal change disease shortly after the second dose of the Moderna COVID-19 vaccine. A previously healthy 51-year-old Asian man presented with lower-limb edema and foamy urine 3 days after receiving the second dose of the vaccine. Laboratory data revealed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Li-Yu, Lee, Chii-Hong, Chiu, I-Jen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424543/ https://www.ncbi.nlm.nih.gov/pubmed/36052319 http://dx.doi.org/10.3389/fmed.2022.844004

Ejemplares similares

Podocytopathy
por: Agarwal, Sanjay K.
Publicado: (2016)

Facial Paralysis Following Influenza Vaccination: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System Database
por: Kamath, Ashwin, et al.
Publicado: (2020)

Drug-induced torsades de pointes: Disproportionality analysis of the United States Food and Drug Administration adverse event reporting system
por: Wu, Ziyang, et al.
Publicado: (2022)

Primary Podocytopathies After COVID-19 Vaccination
por: Timmermans, Sjoerd A.M.E.G., et al.
Publicado: (2021)

Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system
por: Shu, Yamin, et al.
Publicado: (2023)

Human Papillomavirus Vaccination and Premature Ovarian Failure: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System
por: Tatang, Collins, et al.
Publicado: (2021)

A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
por: Zou, Shu-peng, et al.
Publicado: (2023)

Lupus podocytopathy superimposed on diabetic glomerulosclerosis: A case report
por: Liu, Lin, et al.
Publicado: (2021)

Azd-1222/tozinameran: Primary podocytopathy: 4 case reports
Publicado: (2022)

Drug-Induced Podocytopathies: Report of Four Cases and Review of the Literature
por: Athanasopoulou, Diamanto, et al.
Publicado: (2023)

Mitochondrial Oxidative Stress and Cell Death in Podocytopathies
por: Zhu, Yu-Ting, et al.
Publicado: (2022)

Thrombotic microangiopathy triggered by podocytopathy
por: Veríssimo, Rita, et al.
Publicado: (2021)

Unilateral Erosive Arthritis Following Moderna COVID-19 Vaccination
por: Emran, Joseph, et al.
Publicado: (2022)

Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System
por: Ding, Lingqing, et al.
Publicado: (2022)

The Role of Parietal Epithelial Cells in the Pathogenesis of Podocytopathy
por: Li, Zhi-hang, et al.
Publicado: (2022)

Hypertensive Anaphylaxis After Moderna COVID-19 Vaccination: A Case Report
por: Furuto, Yoshitaka, et al.
Publicado: (2022)

Crystalloid podocytopathy with focal segmental glomerulosclerosis in PCM: a case report
por: Jeon, You La, et al.
Publicado: (2015)

Crystalline light chain proximal tubulopathy and podocytopathy: a case report
por: Patel, Ankit B., et al.
Publicado: (2019)

1407. Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS)
por: Timbrook, Tristan T, et al.
Publicado: (2018)

Ototoxic Adverse Drug Reactions: A Disproportionality Analysis Using the Italian Spontaneous Reporting Database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2019)

Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBase
por: Calapai, Fabrizio, et al.
Publicado: (2023)

Lupus podocytopathy and antiphospholipid syndrome in a child with SLE: A case report and literature review
por: Li, Guo-min, et al.
Publicado: (2022)

Adrenocorticotropic hormone analog use for podocytopathies
por: Filippone, Edward J, et al.
Publicado: (2016)

Defining diagnostic trajectories in patients with podocytopathies
por: Cirillo, Luigi, et al.
Publicado: (2022)

Modeling Podocyte Ontogeny and Podocytopathies with the Zebrafish
por: Drummond, Bridgette E., et al.
Publicado: (2023)

Bullous Pemphigoid and Diabetes medications: A disproportionality analysis based on the FDA Adverse Event Reporting System
por: Huang, Liting, et al.
Publicado: (2021)

Post-Marketing Safety Concerns With Secukinumab: A Disproportionality Analysis of the FDA Adverse Event Reporting System
por: Shu, Yamin, et al.
Publicado: (2022)

A real-world disproportionality analysis of apalutamide: data mining of the FDA adverse event reporting system
por: Fang, Zhihong, et al.
Publicado: (2023)

Proarrhythmia associated with antiarrhythmic drugs: a comprehensive disproportionality analysis of the FDA adverse event reporting system
por: Wang, Feifei, et al.
Publicado: (2023)

De novo vasculitis after mRNA-1273 (Moderna) vaccination
por: Anderegg, Manuel A., et al.
Publicado: (2021)

Neurological Adverse Events Associated With Esketamine: A Disproportionality Analysis for Signal Detection Leveraging the FDA Adverse Event Reporting System
por: Guo, Haoning, et al.
Publicado: (2022)

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
por: Liang, Yankun, et al.
Publicado: (2023)

Immune Thrombocytopenia Following Booster Dose of the Moderna mRNA-1273 Vaccine
por: Breetz, Katherine A, et al.
Publicado: (2022)

Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
por: Huang, Jing, et al.
Publicado: (2020)

Spectrum of podocytopathies in new-onset nephrotic syndrome following COVID-19 disease: a report of 2 cases
por: Gupta, Rajib K., et al.
Publicado: (2020)

Suspected Adverse Drug Reactions Related to Breast Cancer Chemotherapy: Disproportionality Analysis of the Brazilian Spontaneous Reporting System
por: Barcelos, Flávia Campos, et al.
Publicado: (2019)

Adverse Event Reporting with Immune Checkpoint Inhibitors in Older Patients: Age Subgroup Disproportionality Analysis in VigiBase
por: Noseda, Roberta, et al.
Publicado: (2021)

Disproportionality analysis of quinolone safety in children using data from the FDA adverse event reporting system (FAERS)
por: Kong, Wenqiang, et al.
Publicado: (2023)

Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system
por: Guo, Haoning, et al.
Publicado: (2022)

Genes and Podocytes – New Insights into Mechanisms of Podocytopathy
por: Bierzynska, Agnieszka, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_stkj5glmfugbh0ornmbibt3658